SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins
Study suggests vaccines, therapeutics, and diagnostics should not be limited to spike protein
(Press-News.org) All coronaviruses produce four primary structural proteins and multiple nonstructural proteins. However, the majority of antibody-based SARS-CoV-2 research has focused on the spike and nucleocapsid proteins. A study published in PLOS Biology by Anna Heffron, Irene Ong and colleagues at the University of Wisconsin-Madison, USA, suggests that immune responses may develop against other proteins produced by the SARS-CoV-2 virus.
The efficacy of spike protein-based vaccines is variable and not everyone infected with SARS-CoV-2 produces detectable antibodies against the spike or nucleocapsid proteins. Therefore, expanded antibody-based options have the potential to play an important role in improving vaccines, diagnostics, and therapeutics, particularly given the emergence of new variants. To investigate whether SARS-CoV-2 infection induces robust antibody responses against all SARS-CoV-2 proteins, researchers mapped 79 "epitopes" - specific regions of the viral proteome that antibodies recognize and bind to. They also tested whether antibodies that develop in response to SARS-CoV-2 or existing antibodies from previous exposures to coronaviruses might bind to any of the proteins in the six other known human coronaviruses to identify potential cross-reactive epitopes.
In addition to spike and nucleocapsid proteins, the authors located previously unknown, highly reactive B cell epitopes throughout the full array of proteins in SARS-CoV-2 and other coronaviruses, expanding the potential for future vaccine and therapeutic development. Future research is needed, however, to determine how long these antibodies remain and whether responses of vaccinated individuals differ from those who contracted COVID-19 prior to vaccination. Dr. Ong and colleagues will continue to investigate these aspects in adults and children.
Although the authors did not directly profile variants of concern that have emerged since the beginning of the COVID-19 pandemic, a comparison of the original SARS-CoV-2 genome with a few of the variants of concern identified numerous variations in regions that are at or within 3 amino acids of identified antibody binding epitopes.
According to the authors, "Our extensive profiling of epitope-level resolution antibody reactivity in COVID-19 convalescent subjects, confirmed by independent assays, provides new epitopes that could serve as important targets in the development of improved diagnostics, vaccines, and therapeutics against SARS-CoV-2, variants of concern, and dangerous human coronaviruses that may emerge in the future".
Peer reviewed; Experimental study; Cells
In your coverage please use these URLs to provide access to the freely available articles in PLOS Biology: http://journals.plos.org/plosbiology/article?id=10.1371/journal.pbio.3001265
Citation: Heffron AS, McIlwain SJ, Amjadi MF, Baker DA, Khullar S, Armbrust T, et al. (2021) The landscape of antibody binding in SARS-CoV-2 infection. PLoS Biol 19(6): e3001265. https://doi.org/10.1371/journal.pbio.3001265
Funding: I.M.O. acknowledges support by the Clinical and Translational Science Award (CTSA) program (ncats.nih.gov/ctsa), through the National Institutes of Health National Center for Advancing Translational Sciences (NCATS), grants UL1TR002373 and KL2TR002374. This research was also supported by 2U19AI104317-06 (to I.M.O via James Gern) and R24OD017850 (to D.H.O.) from the National Institute of Allergy and Infectious Diseases of the National Institutes of Health (http://www.niaid.nih.gov). A.S.H. has been supported by the National Institutes of Health National Research Service Award T32 AI007414 and M.F.A. by T32 AG000213 (http://www.nlm.nih.gov/ep/NRSAFellowshipGrants.html). S.J.M. acknowledges support by the National Cancer Institute, National Institutes of Health and University of Wisconsin Carbone Comprehensive Cancer Center's Cancer Informatics Shared Resource (grant P30-CA-14520; cancer.wisc.edu/research/) and by the National Institute of Allergy and Infectious Diseases of the National Institutes of Health 2U19AI104317-06. This project was also funded through a COVID-19 Response Grant from the Wisconsin Partnership Program and the University of Wisconsin School of Medicine and Public Health (to M.A.S.; http://www.med.wisc.edu/wisconsin-partnership-program/), startup funds through the University of Wisconsin Department of Obstetrics and Gynecology (I.M.O.; http://www.obgyn.wisc.edu/), and the Data Science Initiative (research.wisc.edu/funding/data-science-initiative/) grant from the University of Wisconsin-Madison Office of the Chancellor and the Vice Chancellor for Research and Graduate Education (with funding from the Wisconsin Alumni Research Foundation) (I.M.O.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
Competing interests: I have read the journal's policy and the authors of this manuscript have the following competing interests: The authors declare the following competing interests: A.S.H., S.J.M., D.A.B., M.F.A., S.K., M.A.S., D.H.O., and I.M.O are listed as the inventors on a patent filed that is related to findings in this study. Application: 63/080568, 63/083671. Title: IDENTIFICATION OF SARS-COV-2 EPITOPES DISCRIMINATING COVID-19 INFECTION FROM CONTROL AND METHODS OF USE. Application type: Provisional. Status: Filed. Country: United States. Filing date: September 18, 2020, September 25, 2020.
ELSE PRESS RELEASES FROM THIS DATE:
In a new study published today in the American Journal of Human Genetics, researchers announced the development of a new method to increase the utility and equity of large genetic databases. The research was conducted by Audrey Hendricks, an associate professor of statistics at the University of Colorado Denver (CU Denver).
Summix, the new method developed by Hendricks and her team of CU Denver undergraduate and graduate students, estimates the genetic ancestry in databases and adjusts the information to match the ancestry of a person or sample of people. This method leads large genetic databases to become more useful for people of various ancestries such as African American or Latinx, as they are underrepresented in genetic ...
Every day, our bodies face a bombardment of UV rays, ozone, cigarette smoke, industrial chemicals and other hazards.
This exposure can lead to free-radical production in our bodies, which damages our DNA and tissues. A new study from West Virginia University researcher Eric E. Kelley--in collaboration with the University of Minnesota--suggests that unrepaired DNA damage can increase the speed of aging.
The study appears in the journal Nature.
Kelley and his team created genetically-modified mice with a crucial DNA-repair protein missing from their hematopoietic stem cells, immature immune cells that develop into white blood cells. Without this ...
Broadband sounds embedded with short pauses can maintain temporal sound processing in a mouse model of hearing loss, according to new research published in eNeuro.
Hearing loss treatments supplement auditory system function but don't repair it. However a new intervention -- playing broadband sounds during the onset of hearing loss -- may be able to prevent the damage from ever occurring. Augmented auditory environments have been able to preserve auditory processing of a wide range of sound frequencies in mice models. In a new study, Dziorny et al. modified the traditional paradigm and preserved the processing of time-related, or temporal, sound features which are vital for understanding speech.
The research team exposed mice with congenital hearing loss to ...
DURHAM, N.C. - In the fight against viruses, antibodies have the potential to either block infection or enable infection and make the disease worse, leading to concern about their use as a therapy for COVID-19.
In a study published in the journal END ...
RUDN University doctors found out what role macrophages play in the recovery of the liver after the removal of its significant part. The results are published in the journal Biomedicine & Pharmacotherapy.
The liver in mammals is the most regenerative internal organ. It can restore the original size from as little as 25% of the preserved tissue. An important role in this process is played by macrophages. These are the cells that can engulf and digest particles. It is known, for example, that if the liver is affected by foreign substances, including drugs, macrophages migrate to the liver, absorb harmful microorganisms and dead cells, cause inflammation and thus contribute to the restoration of the organ. However, it is still unknown unambiguously how macrophages affect the ...
Nearly a third of Americans who arranged for paid care for an older person or someone with dementia employed workers who were not hired through a regulated agency, according to a new RAND Corporation study.
Individuals who hired gray market caregivers were less likely to be employed and more likely to also use unpaid care for their family members. In addition, people who lived in rural areas had an almost five-times higher odds of arranging dementia care through gray markets as compared to those who lived in urban areas.
The study is the first national survey to probe the use of gray market care for older adults and people with dementia. The findings ...
HOUSTON - (June 21, 2021) - Rice University engineers have created microscopic seeds for growing remarkably uniform 2D perovskite crystals that are both stable and highly efficient at harvesting electricity from sunlight.
Halide perovskites are organic materials made from abundant, inexpensive ingredients, and Rice's seeded growth method addresses both performance and production issues that have held back halide perovskite photovoltaic technology.
In a study published online in Advanced Materials, chemical engineers from Rice's Brown School of Engineering describe how to make the seeds and use them to grow homogenous thin films, highly sought ...
A team of scientists from NUST MISIS and MIPT have developed and tested a new platform for realization of the ultra-strong photon-to-magnon coupling. The proposed system is on-chip and is based on thin-film hetero-structures with superconducting, ferromagnetic and insulating layers. This discovery solves a problem that has been on the agenda of research teams from different countries for the last 10 years, and opens new opportunities in implementing quantum technologies. The study was published in the highly ranked journal Science Advances.
The last decade has seen significant progress ...
AMHERST, Mass. - Millions of Americans will visit New England's beaches this summer to cool off, play in the waves and soak up the sun. Until now, the factors governing which beaches slope gradually to the sea and which ones end abruptly in a steep drop-off have been largely unknown. However, new research from the University of Massachusetts Amherst reveals, with unprecedented detail, how the grain size of beach sand relates to the slope of the beach itself. These new findings are critical to understanding how New England's beaches will respond to both rising sea levels and increased storm activity.
Many of New England's beaches are made up of a mixture of sand and small stones. Or, to be more precise, the grain sizes on these beaches are "bi-modal" ...
WASHINGTON -- Although quantum technology has proven valuable for highly precise timekeeping, making these technologies practical for use in a variety of environments is still a key challenge. In an important step toward portable quantum devices, researchers have developed a new high-flux and compact cold-atom source with low power consumption that can be a key component of many quantum technologies.
"The use of quantum technologies based on laser-cooled atoms has already led to the development of atomic clocks that are used for timekeeping on a national level," said research team ...
LAST 30 PRESS RELEASES:
[Press-News.org] SARS-CoV-2 infections may trigger antibody responses against multiple virus proteins
Study suggests vaccines, therapeutics, and diagnostics should not be limited to spike protein